November 6, 2020
Restricting Symptoms at the End of Life Decreasing
FRIDAY, Nov. 6, 2020 (HealthDay News) — The occurrence of most restricting symptoms at the end of life has been decreasing during the last 20 years, according to a study published online Nov. 3 in the Journal of the American Geriatrics Society. Thomas M. Gill, M.D., from the Yale School of Medicine in New Haven,...
Considerable Decreases Seen in Health Care Use During COVID-19
FRIDAY, Nov. 6, 2020 (HealthDay News) — During the first two months of the COVID-19 pandemic, there was a considerable decrease in preventive and elective health care use, according to a study published online Nov. 5 in JAMA Network Open. Christopher M. Whaley, Ph.D., from the RAND Corporation in Santa Monica, California, and colleagues examined...
Drug Combo Offers Long-Term Glycemic Control in T2DM
FRIDAY, Nov. 6, 2020 (HealthDay News) — For patients with type 2 diabetes and inadequate glycemic control, exenatide once weekly (QW) plus dapagliflozin shows clinically relevant efficacy and is well tolerated over 104 weeks, according to a study published in the October issue of Diabetes Care. Noting that exenatide QW plus dapagliflozin produced greater reductions...
Vitamin D Supplementation May Aid Severe Dermatitis
FRIDAY, Nov. 6, 2020 (HealthDay News) — Vitamin D supplementation may aid clinical outcomes for pediatric patients with severe atopic dermatitis, according to a study published online Nov. 3 in Pharmacology Research & Perspectives. Noha O. Mansour, Ph.D., from Mansoura University in Egypt, and colleagues randomly assigned 86 pediatric patients with severe atopic dermatitis to...